Usually, c-Met expression is very low in normal tissues, but it is dysregulated in many types of carcinomas as a result of gene amplification, activating mutations, dimerization from overexpression, and autocrine or paracrine stimulatory mechanisms [29]. This evidence concerns the gene MET and carcinoma.